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Abstract
Background: Tinnitus affects about 10-15% of the general population and risks for developing tinnitus are rising
through increased exposure to leisure noise through listening to personal music players at high volume. The
disorder has a considerable heterogeneity and so no single mechanism is likely to explain the presence of tinnitus
in all those affected. As such there is no standardized management pathway nor singly effective treatment for the
condition. Choice of clinical intervention is a multi-factorial decision based on many factors, including assessment
of patient needs and the healthcare context. The present research surveyed clinicians working in six Westernized
countries with the aims: a) to establish the range of referral pathways, b) to evaluate the typical treatment options
for categories of subjective tinnitus defined as acute or chronic, and c) to seek clinical opinion about levels of
satisfaction with current standards of practice.
Methods: A structured online questionnaire was conducted with 712 physicians who reported seeing at least one
tinnitus patients in the previous three months. They were 370 general practitioners (GPs) and 365 ear-nose-throat
specialists (ENTs) from the US, Germany, UK, France, Italy and Spain.
Results: Our international comparison of health systems for tinnitus revealed that although the characteristics of
tinnitus appeared broadly similar across countries, the patient’s experience of clinical services differed widely. GPs
and ENTs were always involved in referral and management to some degree, but multi-disciplinary teams engaged
either neurology (Germany, Italy and Spain) or audiology (UK and US) professionals. For acute subjective tinnitus,
pharmacological prescriptions were common, while audiological and psychological approaches were more typical
for chronic subjective tinnitus; with several specific treatment options being highly country specific. All therapy
options were associated with low levels of satisfaction.
Conclusions: Despite a large variety of treatment options, the low success rates of tinnitus therapy lead to
frustration of physicians and patients alike. For subjective tinnitus in particular, effective therapeutic options with
guidelines about key diagnostic criteria are urgently needed.
Background
Tinnitus is defined as a perceived noise of varying inten-
sity, loudness and pitch in the absence of an external
sound [1,2] Although the experience of short bursts of
noise is almost universal, tinnitus is typically defined as
noise that lasts at least 5 minutes [3]. Tinnitus can be
either acute or chronic. In the present study, chronic
tinnitus is defined as a condition lasting longer than
three months. Its prevalence is reported to be about 10
to 15% of the general population, but it is more com-
mon in adults, especially older adults [4]. For example,
12% of over 60 year olds, but only 5% of 20 to 30 year
olds are reported to experience chronic tinnitus [5].
Tinnitus is described as subjective or objective. While
objective tinnitus has a physical explanation for the per-
ceived sound, subjective tinnitus can be heard only by
the sufferer (i.e. a ‘phantom sensation’). Objective
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tinnitus is therefore the main topic of this publication.
Among severe sufferers, tinnitus causes disability asso-
ciated with concentration deficits, insomnia, hypersensi-
tivity to sounds, anxiety and depression. Often a
combination of several complaints leads to a diminished
quality of life [6,7] For example, it is estimated that for
about 1 in 100 of the general population, the condition
severely affects their quality of life [2]. Emotional dis-
tress is not simply related to tinnitus loudness; it
depends furthermore on whether the tinnitus is per-
ceived as threatening [8]. In this respect, tinnitus can be
described as ‘compensated’ (i.e. the patient notices the
noise in his/her ear or head, but it does not impair qual-
ity of life) or ‘not compensated’ (i.e. a severe condition
that severely impacts on quality of life, with the possible
development of secondary symptoms such as anxiety).
Pathophysiology
It has been estimated that 85% of tinnitus cases are
accompanied by hearing loss and that occupational and
leisure noise are the greatest factors causing cochlear
damage [9]. Clinically, tinnitus is not a unitary condition
and its aetiology has also been associated with head and
neck injuries, ototoxic drugs, vascular and cerebrovascu-
lar diseases, systemic disorders, infectious disease, auto-
immune disorders, ear conditions and temporo-
mandibular joint disorders [10]. Despite these various
causes, it is now well established that the central audi-
tory system plays an important role in the perception of
tinnitus [11]. Recent research showed that changes in
neuronal activity might underlie tinnitus pathology, but
our knowledge of the precise neural substrates of tinni-
tus is still limited also because studies have difficulties
to separate what changes have been induced by hearing
loss and what are specifically associated with tinnitus
[1,12].
Treatment options
Currently there is no cure for tinnitus [13], nor are
there any licensed medications for alleviating the symp-
toms. For example, there is no Food and Drug Adminis-
tration (FDA) or European approved drug specifically
for treating subjective tinnitus [14]. Reasons that ham-
per the identification of good candidates for an effective
pharmacological treatment for tinnitus include the het-
erogeneity of tinnitus and our limited knowledge about
the pathophysiology of the different forms of tinnitus.
Consequently, a majority of tinnitus treatment options
are primarily directed towards alleviating or managing
the accompanying symptoms making the tinnitus less
intrusive or less distressing.
Several comprehensive reviews of the therapeutic
options are provided in the literature [11,15]. Most
common approaches include education, acoustic devices
(hearing aids, noise generators, combination devices),
psychological therapy (e.g. cognitive-behavioural therapy,
counselling and relaxation), Tinnitus Retraining Therapy
(TRT), and complementary treatments such as acupunc-
ture. Acoustic devices enrich the sound environment
and can thus be helpful in diminishing patients’ aware-
ness of their tinnitus, while a majority of clinical
‘packages’ involve psychological and/or educational com-
ponents aimed at changing the emotional meaning of
the tinnitus in order to reduce personal distress [16]. A
good source of evidence for the efficacy of the various
treatment options is collated in the Cochrane Collection
http://www2.cochrane.org/reviews which provides major
reviews of tinnitus-related publications. However, exami-
nation of this resource indicates rather contradictory or
poor-quality evidence for a number of strategies used in
current practice.
Pharmacological treatments are also widely available
for reducing the various co-morbid symptoms such as
depression and insomnia. The most frequently used
drug options were recently summarized by Langguth
and colleagues [14]. Due to the comorbidity of depres-
sion in some chronic tinnitus patients, antidepressants
are commonly used. Antidepressants may be able to
alleviate sleep problems and other depressive symptoms
for some severely distressed patients. It has been recom-
mended that they should be used in combination with
psychological therapy for the most effective management
of tinnitus [15]. Other drugs include tranquillisers (espe-
cially benzodiazepines), anti-vertigo products (e.g. cin-
narizine), coronary drugs (especially niacin), local
anaesthetics (e.g. lidocaine), or natural remedies/supple-
ments (e.g. bioflavonoids, zinc). In Germany, a local pre-
ference has been rheological infusion which is thought
to improve the rate of blood flow, but reimbursement
for this type of treatment ceased in 2009. Again, the effi-
cacy of these drugs in relieving the symptoms of tinnitus
is uncertain.
Clinical practices
While the number of different treatment options for tin-
n i t u si sg r o w i n g ,v e r yf e ws t u d i e sh a v ee x a m i n e dt h e
extent to which this has impacted on clinical practice.
Of all the different specialties that contribute to tinnitus
referral and management, general practitioners (GPs)
and otolaryngology specialists (ENTs) play substantial
roles in all six countries that were surveyed. Our survey
therefore targets these two professions. From their
postal survey of general practitioners (GPs) in the UK,
Vanniasegaram and colleagues [17] concluded that there
was a substantial discrepancy between the scientific and
technological perspectives on the management of tinni-
tus and the actual day-to-day practice in the primary
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almost 20 years on. A national postal survey of GPs in
the UK conducted by El-Shunnar and colleagues [18]
highlighted similar findings. Although some GPs high-
lighted little demand for tinnitus management within
their practice, many others expressed an unmet need for
specific and concise training on tinnitus management.
Patients themselves also express dissatisfaction. For
example, a recent telephone survey of members of the
Irish Tinnitus Association revealed that many healthcare
professionals (especially GPs) appeared to have limited
awareness of developments in the therapeutic field and
provided little advice or information to help people
manage their condition [19]. This finding was recently
echoed in a survey conducted in Northern Ireland by
the Royal National Institute for Deaf People (RNID)
[20]. One way to address the problem would be to
include tinnitus management in the training curriculum
for medical students and/or GPs [17,20]. To our knowl-
edge this has not been taken up and so alternatively
protocols (flowcharts) for diagnosis and treatment could
be made available. First efforts towards the development
of flowchart for diagnosis and management have been
initiated [21,22], but a widely accepted protocol for how
to diagnose and refer or select an appropriate treatment
option has yet to be established. Hoare and Hall [23]
have recently argued that some degree of standardiza-
tion in practice is essential for identifying key standards
of best practice for tinnitus, for ensuring equal patient
access to treatments, for facilitating clinical audit, and
for providing high-level evidence of clinical efficacy. Sev-
eral organisations have recently introduced standardized
protocols, developed from broad collaborative efforts. In
the UK, the Good Practice Guide (GPG) document pro-
duced by the Department of Health is targeted at man-
agers in the National Health Service [21].
The Tinnitus Research Initiative (TRI) more recently
produced a document targeted at an international audi-
ence of hearing practitioners and medical specialists
[22]. Both protocols address diagnostic assessment and
treatment, but the TRI document focuses heavily on a
medical model of tinnitus management, while the GPG
is more representative of a patient-centred approach. In
t h eU Ka tl e a s t ,t h ei n f l u e n c eo ft h eG P Gh a sb e e n
somewhat limited [24] and on the international front
perhaps it is too premature to expect any impact from
the TRI document. Today it would seem that the choice
of treatment remains largely in the hands of the indivi-
dual clinical professional, perhaps influenced also by
country-specific training routes and practices, schemes
for reimbursement from medical insurance, other local
resource limitations and patient preference.
With this survey, we aim to shed some light on the
way physicians working in different countries report
handling acute and chronic tinnitus and to find their
preferred modes of treatment. Finding possible country-
specific preferences in treating tinnitus patients may
help to uncover possible weak points in patient care and
medical alternatives, and to find a more standardized
approach of treatment. We use an online questionnaire
administered to a sample of physicians to explore num-
ber of tinnitus patients consulted in the past three
months, pathogenesis (subjective vs objective), duration
(acute vs chronic), severity (compensated vs not com-
pensated), referral, responsibility for diagnosis and man-
agement, normal treatment options and their perceived
success rate of treatment. A number of questions speci-
fically asked about the range of pharmaceutical treat-
ments used as first and second line approaches, and
satisfaction with those medications. In particular, we
aim to highlight differences between the two clinical
professions and also between clinical practices in six
countries. Our discussion seeks to contextualize some of
these findings into the specific healthcare system operat-
ing within the different countries.
Methods
Questionnaire
The online survey was performed by DocCheck Medical
Services GmbH for Merz Pharmaceuticals GmbH
between February 6
th and March 2
nd 2007. The ques-
tionnaire consisted of 16 questions requiring a range of
numerical responses, self ratings and open text
responses, including self-report estimates of the number
of tinnitus patients consulted in the past 3 months,
pathogenesis, duration, severity, referral, diagnosis, man-
agement, success rate, and satisfaction (Appendix 1).
Four of the questions specifically related to pharmaceu-
tical treatments for tinnitus. Questionnaire translation
was a multi-step process. A master version was prepared
in English and then translated into German, Italian,
Spanish and French. A native speaker worked indepen-
dently to proofread each translation. The questionnaire
was scripted with the software Umfragecenter
®.
Recruitment approach
The research institute DocCheck, Germany, together
with its international partners offers country-wide panels
of thousands of physicians from all clinical specialties
who are willing to share their expert views in anon-
ymous online market research. Although this is a volun-
tary sample from those registered in the GP and ENT
communities, the demographic distribution of respon-
dents (age, gender, region) is cross-checked against
available population statistics for the two professions to
provide some assurance about representativeness. Target
countries for this survey were the USA and five Eur-
opean countries (UK, Germany, France, Spain and Italy).
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out to the relevant specialty panels. Physicians qualified
t op a r t i c i p a t ei nt h i ss u r v e yi ft h e yw e r eg e n e r a lp r a c t i -
tioners/primary care physicians (thereafter denoted as
GPs) or otolaryngologists/Ear-Nose-Throat specialists
(thereafter denoted as ENTs). From each country, GPs
and ENTs were recruited in equal proportions. Approxi-
mate quotas were pre-set for each country. In the US, it
was 200 and in European countries it was 100. As far as
possible, recruitment considered demographic and
regional variables.
Respondents
Overall, 370 GPs and 365 ENTs were surveyed. Seven-
teen GPs and 6 ENTs (mostly in the US) were screened
out because they had not seen any tinnitus patients in
the last three months, leaving a total of 712 respondents
(Table 1), with an average age of 49 years. Typically,
these respondents were male. For GPs, 76% were male
(267/353) and for ENTs, 83% were male (297/359).
Results
Number of tinnitus patients consulted in the last three
months
Table 2 reports the distribution of the number of esti-
mated consultations for tinnitus in the preceding three-
month period. From the total number of 735 respon-
dents, the median number of GP consultations was 10-
19. In all countries, the distribution for ENTs tended to
appear shifted upwards such that the median number of
ENT consultations for the same period was 30-49. Ger-
many appeared to be a prominent exception since 70%
of responding ENTs estimated that they had more than
100 appointments with tinnitus patients in the three-
month period.
Table 3 reports the estimated numbers of new patients
reporting tinnitus. For GPs, the median number was 1-4
new consultations in the past three months. Hence we
can infer that a substantial majority of tinnitus consulta-
tions are with people who have repeated appointments.
For ENTs, the median number of new patients was sub-
stantially higher than for GPs (20-29). We can infer that
the caseload for ENTs is more evenly balanced across
new and repeating patients.
For the subsequent analyses, we included only those
healthcare professionals who reported a consultation
with at least one tinnitus patient within the past three
months. Hence, 17 GPs and 6 ENTs were excluded (see
also Tables 1 and 2). The analysis is primarily presented
in the form of descriptive statistics reporting the percen-
tage of responses across eachp r o f e s s i o n .M a n yo ft h e
questions relate to subjective tinnitus and these
responses are split by country to paint a picture of the
international variations. Typical treatment options, their
perceived success rate, and range of pharmacological
options were analysed separately for acute and chronic
subjective tinnitus.
Pathogenesis
A small number of physicians indicated a lack of under-
standing of the terminology (’subjective/objective’).
Overall, 13 GPs (US 4; UK 3; France 4; Spain 2) and 3
ENTs (US 1; Spain 1; Italy 1) reported unfamiliarity
with this classification. Of those GPs and ENTs remain-
ing, subjective tinnitus was judged to account for about
three quarters of cases (65-82% for GPs and 71-88% for
ENTs). Table 4 reports the percentage of patients
reporting subjective and objective tinnitus across the six
countries. Results demonstrate how objective tinnitus
represents the minority of tinnitus cases.
Table 1 Total number of participating physicians and their demographic characteristics.
Profession Gross sample
[N]
Sample after screening
[N]
Male
[N]
Female
[N]
Average age
[years]
US GPs 117 102 70 32 42
ENTs 106 102 88 14 48
UK GPs 52 51 40 11 47
ENTs 54 53 49 4 46
Germany GPs 51 50 34 16 50
ENTs 50 50 36 14 52
France GPs 50 50 43 7 49
ENTs 50 50 43 7 51
Spain GPs 50 50 39 11 49
ENTs 52 52 39 13 50
Italy GPs 50 50 41 9 52
ENTs 53 52 42 10 51
GP = General practitioner, ENT = Ear-Nose-Throat specialist. Screening excluded those physicians who had not seen any tinnitus patients in the past three
months. All values represent total numbers (except age, which represents an average).
Hall et al. BMC Health Services Research 2011, 11:302
http://www.biomedcentral.com/1472-6963/11/302
Page 4 of 15Duration
Chronic tinnitus (≥ 3 months) was reported to account
for 64% of cases overall (Table 5). There were no strik-
ing differences in the pattern between GPs and ENTs,
nor between the six countries.
Severity
There were no striking differences in the pattern
between GPs and ENTs, nor between the six countries
(Table 6). Typically, patients with compensated
symptoms were slightly in the majority (GPs: 51-66%,
ENTs: 58-74%). It is perhaps somewhat surprising to
find that patients whose tinnitus does not substantially
impact on their quality of life appeared to be the ones
most often seeking help. We rule out a lack of under-
standing of the terminology (’compensated/not compen-
sated’) since only 13 GPs (US 9; UK 3; France 1) and 2
ENTs (US 1; France 1) reported unfamiliarity with this
classification. It is therefore possible that a substantial
number of consultations either just require advice and
Table 2 Number of professionals and their estimate of the number of tinnitus consultations in the last three months.
GP profession
# patients consulted US UK Germany France Spain Italy GP total
01 5 1 1 - - - 1 7
1-4 28 13 3 4 9 8 65
5-9 18 11 11 10 6 12 68
10-19 26 13 14 15 16 17 101
20-29 16 7 6 11 8 6 54
30-49 11 4 11 6 4 6 42
50-99 3 2 5 3 7 1 21
>100 - 1 - 1 - - 2
ENT Profession
# patients consulted US UK Germany France Spain Italy ENT total
04 1 - - - 1 6
1-4 3 1 - 1 - - 5
5-9 2 1 - - 1 6 10
10-19 13 5 2 9 7 13 49
20-29 18 8 2 8 8 7 51
30-49 21 13 2 14 18 10 78
50-99 26 17 9 10 10 9 81
>100 19 8 35 8 8 7 85
GP profession
# new patients consulted US UK Germany France Spain Italy GP total
02 0 5 2 - 1 1 2 9
1-4 45 32 25 23 18 35 178
5-9 22 7 17 17 14 10 87
10-19 25 6 6 10 12 4 63
20-29 5 - 1 - 2 - 8
30-49 - 2 - - 2 - 4
50-99 - - - - 1 - 1
>100 - - - - - - 0
ENT profession
# new patients consulted US UK Germany France Spain Italy ENT total
04 1 - - - 1 6
1-4 8 3 1 4 2 10 28
5-9 9 1 1 6 9 11 37
10-19 23 11 6 21 18 10 89
20-29 21 12 6 9 12 10 70
30-49 14 13 10 2 6 8 53
50-99 19 10 11 5 4 2 51
>100 8 3 15 3 1 1 31
Data are reported separately across the two professions and each country.
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some treatment which does alleviate associated symp-
toms, but that those symptoms nonetheless are not
judged to impair quality of life. Ear wax removal and
nocturnal sedation are two possible examples given in
the UK GPG [21].
Referral to GPs and ENTs
F o rt h i sq u e s t i o ni nt h es u r v e y( Q 3 ,A p p e n d i x1 ) ,
respondents were asked to consider their last 10 patients
with subjective tinnitus. Responses tell us about the pro-
portion of those patients who directly accessed the
service and those who were referred from elsewhere.
Reports are summarized in Table 7 as percentages. In
the case of GPs, almost all tinnitus patients (>90%)
came to the surgery directly (without a referral). As
expected, the proportion of ‘direct access’ patients was
somewhat lower for ENTs (45-60% in all countries
except Italy), with some apparent variation across coun-
tries. For example, in the UK only 14% of tinnitus cases
in ENT surgeries were direct access, while in Italy this
estimate reached 68%. This finding is most likely to
reflect differences in the healthcare systems. In the UK
for example, direct access to specialist services is rarely
an option for patients [25].
The physicians were also asked about the type of
healthcare professionals who referred cases of subjective
tinnitus to them (Q4, Appendix 1). A range of options
included GPs, other ENTs, neurologists, psychothera-
pists or specialists in psychosomatic disorders, neurosur-
geons, radiologists, audiologists and paediatricians.
Responses from GPs on this question are not so infor-
mative since such a large number of cases are direct
access. For ENTs with referred patients, at least 89% in
all countries reported that GPs referred patients to
them. Audiologists seemed to play an important role in
those countries where audiology is a recognized profes-
sion in its own right, with 55% of UK ENTs stating
receiving such referrals, and 32% of US ENTs. In all
countries except France (6%), ENTs also listed neurolo-
gists as another key source of referrals (>20%), with this
being particularly high in Germany (44%). This may be
related to the fact that in Germany many neurologists
are both neurologists and psychiatrists.
Diagnosis and onward referrals
Table 8 reports percentages of reported patients who
were diagnosed as having tinnitus by another specialist
before reaching the respondent, those who were diag-
nosed by the physician themselves and those who
Table 3 Number of professionals and their estimate of
the number of new tinnitus consultations in the last
three months.
GP profession
# new patients
consulted
US UK Germany France Spain Italy GP
total
02 0 5 2 - 1 1 2 9
1-4 45 32 25 23 18 35 178
5-9 22 7 17 17 14 10 87
10-19 25 6 6 10 12 4 63
20-29 5 - 1 - 2 - 8
30-49 - 2 - - 2 - 4
50-99 - - - - 1 - 1
>100 - - - - - - 0
ENT profession
# new patients
consulted
US UK Germany France Spain Italy ENT
total
04 1 - - - 1 6
1-4 8 3 1 4 2 10 28
5-9 9 1 1 6 9 11 37
10-19 23 11 6 21 18 10 89
20-29 21 12 6 9 12 10 70
30-49 14 13 10 2 6 8 53
50-99 19 10 11 5 4 2 51
>100 8 3 15 3 1 1 31
Data are reported separately across the two professions and each country.
Table 4 Percentage of patients classified as having
subjective or objective tinnitus, split by each country,
and reported separately for each professional group.
GP profession ENT profession
Country Subjective
[%]
Objective
[%]
Subjective
[%]
Objective
[%]
US 72 28 78 22
UK 75 25 88 12
Germany 82 18 86 14
France 77 23 83 17
Spain 65 35 75 25
Italy 71 29 71 29
Data are reported only for those physicians who reported seeing at least one
tinnitus patient in the past three months.
Table 5 Percentage of patients classified as having
chronic (≥ 3 months) or acute (< 3 months) tinnitus, split
by each country, and reported separately for each
professional group.
GP profession ENT profession
Country Chronic
[%]
Acute
[%]
Chronic
[%]
Acute
[%]
US 50 50 69 31
UK 68 32 81 19
Germany 66 34 53 47
France 59 41 71 29
Spain 49 51 72 28
Italy 61 39 66 34
Data are reported only for those physicians who saw at least one tinnitus
patient in the past three months.
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Appendix 1).
The proportion of tinnitus cases diagnosed by the GP
themselves was almost 60% in all countries except Ger-
many (37%). The proportion patients with a ‘pre-diagno-
sis’ was small in GP surgeries (11-20%), while the
number of patients who were referred by a GP on to a
colleague for a diagnosis accounted for about 25% in the
US, UK and Spain, and slightly less in France (18%).
Particularly in Germany, but also in Italy, considerably
more patients were referred for diagnosis (43% and 35%
respectively). These numbers may reflect easier access to
relevant specialist care in these two countries.
The physicians were asked about the type of health-
care professionals they referred their patients to for
diagnosis. Predominantly such a colleague was judged
to be an ENT specialist (>90% of GPs referring
patients for diagnosis reported to do so to an ENT
specialist). This pattern is possibly indicative of the
dominance of otolaryngology as the medical specialty
for hearing-related disorders (see Discussion for
further details). In Germany and Italy, where a smaller
percentage of GPs diagnosed tinnitus themselves, GPs
typically chose to refer on to an ENT doctor and a
neurologist (Table 8). In Germany, estimates indicated
100% of onwards referrals were to ENT with 46% also
to a neurologist. Similarly in Italy, 92% of onward
referrals were judged to be to ENT with 38% also to
neurology.
ENTs estimated that they diagnosed about the same
proportion of tinnitus cases themselves as did GPs
(61-74%). Generally, ENTs received more pre-diag-
nosed cases (about 27%) than did GPs, while a smaller
proportion (4-10%) was referred elsewhere. Such
onward referrals were made to a variety of healthcare
professionals including neurologists, radiologists, and
audiologists. It is interesting to note that in the UK,
none of the ENT respondents reported making a refer-
ral to neurology, while in all other countries this
accounted for 32-60% of such onward referrals, even
in the US. According to the responses, the patterns
reported for ENT were more consistent between the
other four European countries.
Management and onward referrals for management
The questionnaire asked about patients with subjective
tinnitus who were managed by the respondent and
those who were referred on for management (Q7,
Appendix 1). Reports are summarized in Table 9.
GPs in all countries stated that around two thirds of
patients (58-71%) were managed by themselves. Of the
remaining patients that were referred on for manage-
ment, it was mainly to ENTs (stated by ≥89% of GPs),
which agrees internally with the information given by
ENTs about the source of their referrals. It is interesting
to note that a recent independent survey conducted in
England found that GPs referred on 37% of tinnitus
patients, most of which were either to ENT (82%) or
audiology (12%) [18]. These values provide some exter-
nal corroboration for the UK-bases estimate in the pre-
sent study where 33% of tinnitus patients were referred
on by GPs. The proportion of tinnitus patients who
were treated by ENTs themselves was at least 90% in
each country, except in the UK (79%). Here, of the
remaining 21% that were referred on, it was mostly to
Table 6 Percentage of patients classified as having tinnitus symptoms that are not compensated or compensated,
split by each country, and reported separately for each professional group.
GP profession ENT profession
Country Not compensated [%] Compensated
[%]
Not compensated [%] Compensated
[%]
US 34 66 26 74
UK 41 59 35 65
Germany 47 53 30 70
France 49 51 35 65
Spain 39 61 39 61
Italy 40 60 42 58
Data are reported only for those physicians who saw at least one tinnitus patient in the past three months.
Table 7 Percentage of patients with subjective tinnitus
who directly accessed the consultation with the
physician and those who were referred by another
healthcare professional, split by each country, and
reported separately for each professional group.
GP profession ENT profession
Country Direct
[%]
Referred[%] Direct
[%]
Referred
[%]
US 94 6 45 55
UK 98 2 14 86
Germany 94 6 55 45
France 96 4 57 43
Spain 93 7 60 40
Italy 95 5 68 32
Data are reported only for those physicians who saw at least one tinnitus
patient in the past three months.
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(13%), and hearing therapists (10%).
In summary, our findings highlight the important role
of GPs and ENTs in the diagnosis and management of
tinnitus across all six countries. In those countries sur-
veyed, GPs and ENTs played a frequent role in the diag-
nosis and management of tinnitus, while such a role for
other professions such as neurology, radiology and psy-
chology differed across countries. In Germany, neurol-
o g yw a st h ep r e d o m i n a n t‘external’ speciality with the
largest proportion of tinnitus cases, with Italy and Spain
following behind. In these countries, neurologists seem
to play an important role in both diagnosis and manage-
ment. Interestingly, neurology was never the choice for
diagnosis or management for UK ENT respondents (9%
of UK GPs referred patients to neurologists for manage-
ment). Instead in the UK, audiology dealt with the
greatest number of tinnitus referrals by ENTs (68%)
with 36% of US-based ENTs also following the same
commissioning route. This is consistent with the recog-
nition of audiology as an independent profession in
these two countries (see Discussion). In all six countries,
ENTs occasionally mentioned radiologists, but this was
primarily in a diagnostic role, not for management. For
example, the TRI guidelines recommend angiography,
magnetic resonance imaging or echo-doppler testing in
cases of pulsatile tinnitus that is suspected to be asso-
ciated with a non-otological cardiovascular condition. In
the UK, tinnitus with sudden or rapidly progressive
hearing loss is a ‘red flag’ for immediate referral to
another medical discipline, such as radiology [21].
The physicians were asked about treatments normally
offered to people with subjective tinnitus (Q9, Appendix
1). Respondents chose from 10 options, with no restric-
tion on the number of options that could be selected.
For clarity, treatment options for acute and chronic tin-
nitus are reported separately.
Typical treatment options for acute tinnitus
About half of all responding GPs reported the use of a
pharmaceutical treatment as a course of treatment for
acute tinnitus (average = 77.1%). GPs in Italy and Spain
reported the highest usage of medication as a treatment
option (98% and 94%, respectively), with the UK (49%)
and US (64%) reporting the least usage. The next most
popular form of treatment offered in all countries was
some form of alternative therapy (average = 16.1%),
used most widely in Germany (36%). Other treatments
were used to a lesser extent and showed some degree of
preference by country. Psychological treatment was
most common in France, Spain, Germany, and the US
(16-20%), while GPs in the UK and the US tended to
offer forms of tinnitus retraining therapy (14% and 16%,
respectively). In the UK, there is a severe shortage of
qualified clinical psychologists and psychotherapists for
tinnitus counselling, and so GPs are advised [21] to pro-
vide ‘informational counselling’ which is based on tech-
nical education and information giving. Audiology
departments in the UK are expected to provide some
form of counselling, but this more typically relates to
personal adjustment counselling as part of the
Table 8 Percentage of patients reported to have been diagnosed as having tinnitus by another specialist before
reaching the respondent (’pre-diagnosed’), diagnosed by the physician themselves (’Self’) or needing to be referred
on for diagnosis (’Referred on’).
GP profession ENT profession
Country Pre-diagnosed [%] Self
[%]
Referred on
[%]
Pre-diagnosed [%] Self [%] Referred on [%]
US 13 62 25 24 71 5
UK 14 63 23 31 63 6
Germany 20 37 43 23 68 9
France 15 66 18 35 61 4
Spain 14 59 26 22 74 4
Italy 11 54 35 28 63 10
Data are split by each country, and reported separately for each professional group. Again, only data for those physicians who saw at least one tinnitus patient in
the past three months are reported.
Table 9 Percentage of patients with subjective tinnitus
that are managed by the physician themselves (’Self’)o r
are referred on for management by another specialist
(’Referred on’), split by each country, and reported
separately for each professional group.
GP profession ENT profession
Country Self
[%]
Referred on [%] Self
[%]
Referred on [%]
US 67 33 94 6
UK 67 33 79 21
Germany 69 31 92 8
France 71 29 92 8
Spain 69 31 96 4
Italy 58 42 90 10
Data are reported only for those physicians who saw at least one tinnitus
patient in the past three months.
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Page 8 of 15audiological rehabilitation which is targeted towards
helping patients to confront a range of psychological,
social and emotional concerns as they relate to audiol-
ogy. Acoustic devices were reported to be offered to
patients with acute tinnitus in the US (25%) and in the
UK (14%), probably reflecting the recognized status of
the audiological profession in these healthcare systems.
Physical therapy was most prevalent in France, Ger-
many, the US and Italy (15-26%). This type of therapy
mobilizes joints and massages soft tissue. GPs in Ger-
many were noted as the only primary-care practitioners
to substantially refer patients to hyperbaric oxygenation
treatment (16%), which delivers oxygen to the patient at
a level higher than atmospheric pressure. These findings
are illustrated in Figure 1 (top left hand panel).
Again, most responding ENTs reported pharmaceuti-
cal treatments for acute tinnitus (average = 69.9%),
although the UK was considerably lower than this aver-
age (19%) (see Figure 2, bottom left hand panel). Instead
in the UK, acoustic equipment (43%) and tinnitus
retraining therapy (38%) were the most preferred treat-
ment options, with possible reasons for this pattern hav-
ing already been presented above. Acoustic devices were
also a common option for ENTs in the US (33%) and in
the UK (43%). In Germany, the low numbers of ENTs
considering acoustic treatments (10%) is probably indi-
cative of a healthcare system in which otolaryngologists
in private practice and in hospitals do not stock hearing
aids [26]. ENTs practicing in Italy were more likely to
offer hyperbaric oxygenation treatment (25%) than
ENTs elsewhere, while physical therapy was popular in
German ENT clinics (30%).
Typical treatment options for chronic tinnitus
G P si na l ls i xc o u n t r i e se s t i m a t e dt h a tt h e yu s e dp h a r -
maceutical therapies considerably less often for chronic
tinnitus than they did for acute tinnitus (average =
55.8%) (Figure 1, top right hand panel). France and
Spain were those countries with the highest proportion
of drug treatments (74% and 78% respectively), with
Italy (66%) and Germany (52%) trailing. For chronic tin-
nitus however, acoustic devices (average = 36.3%) and
psychological treatment (average = 35.1%) were com-
monly offered by GPs in all six countries, with alterna-
tive therapies the next most popular option (average =
26.6%). Physical therapy stood out as one of the most
popular options in Italy (38%), behind that of a pharma-
ceutical approach.
For ENTs, there was again a reduction in the preva-
lence of pharmaceutical medication in cases of chronic
Figure 1 Number of physicians reporting the availability of a range of normal treatment options for acute and chronic tinnitus,
reported separately by GPs and ENTs.
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Page 9 of 15tinnitus (Figure 1, bottom right hand panel) compared
with acute tinnitus, particularly in Germany. In the UK,
drugs were rarely offered (15%). Across all countries, the
preference of ENTs offering acoustic equipment, psy-
chological treatment and tinnitus retraining therapy to
tinnitus patients was greater for chronic cases (averages
= 68.8%, 42.3% and 52.4%, respectively) than for acute
cases (averages = 20.6%, 15.0% and 14.5%, respectively).
Alternative therapy also counted for a substantial pro-
portion of the available treatment options for chronic
tinnitus (average = 25.9%) and physical therapy was
again popular in Germany (34%).
One general interpretation of the data presented in
Figure 1 is that the range of treatments offered by an
individual physician is broader in scope for chronic tin-
nitus than for acute tinnitus. This is evidenced by the
height of the bars in each panel.
Furthermore, the questionnaire asked about first-line
treatment options for patients with acute and chronic
subjective tinnitus (Q10, Appendix 1). Broadly speaking,
the patterns emerging were equivalent to the results
reported above for the previous question. However,
responses to this question gave additional information
about the proportion of patients not treated and results
showed that about 21% of cases did not receive any spe-
cific treatment. This proportion did not markedly differ
across professions (i.e. GP vs ENT) or pathology (i.e.
acute vs chronic tinnitus). However, several country-spe-
cific patterns are noteworthy. In Germany, very few
acute cases remained untreated by GPs (12%) and ENTs
(2%). In contrast, in the UK, a relatively high proportion
of acute cases were reported not to be offered a first-
line treatment (GPs = 44% and ENTs = 54%).
Another question asked about first-line pharmaceuti-
cal treatments for patients with acute and chronic sub-
jective tinnitus (Q11, Appendix 1). Respondents chose
from 17 options, with no restriction on the number of
options that could be selected. Again, for clarity, treat-
ment options for acute and chronic tinnitus are reported
separately.
Pharmaceutical treatments used as a first-line approach
for acute tinnitus
Rather broad diversity in drug treatments was noted for
acute tinnitus (Figure 2, left hand panels). However GPs
tended to prefer anti-vertigo products in all countries
Figure 2 Proportion of patients (%) offered particular pharmaceutical treatments as a first line approach for acute and chronic
tinnitus, reported separately by GPs and ENTs.
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Page 10 of 15(average = 65.4%), except in Germany (37%). Here rheo-
logical infusion treatment dominated as the medical
approach of first choice (93%). We have already noted
that rheological infusion was little reported elsewhere.
Other features of GP practice in Germany were the pre-
ference for ginkgo preparations (37%) and corticoster-
oids (26%). Ginkgo biloba was also often used in France
(35%), while corticosteroids were also common as a
first-line treatment in the US (31%). Again, these drugs
were prescribed less frequently elsewhere. In Italy and
Spain, tranquillisers were often prescribed for acute
forms of tinnitus (41% and 43%, respectively). In Spain
and France, nootropics and coronary drugs accounted
for 30-32% of the drugs recommended by GPs for acute
tinnitus, while in Italy platelet aggregation inhibitors
accounted for about 31% of the drugs used in that coun-
try. These drugs are effective for preventing arterial
thrombosis.
Results for ENTs are shown in the bottom left hand
panel of Figure 2. Among ENTs in all countries, anti-
vertigo products were mentioned considerably less often
(average = 37.5%) than in GP practice, and in Germany
these accounted for only 13% of all drugs recommended
by ENTs for acute tinnitus. Like GPs in Germany, ENT
specialists also favoured rheological infusion (89% of all
drug treatments). Also of note was the greater use of
corticosteroids by ENTs in all six countries (average =
50.6%) compared to GPs (average = 20.6%). Ginkgo
biloba remained a popular fir s tl i n ec h o i c e( a v e r a g e=
34.2%), except in the UK (20%). In Spain, calcium
antagonists accounted for 52% of drug treatments, while
ENTs in France used coronary drugs most often (51%).
In Italy, ENTs (like their GP counterparts) preferred the
use of platelet aggregation inhibitors (45%) as one of the
first-line pharmaceutical options.
Pharmaceutical treatments used as a first-line approach
for chronic tinnitus
Once again, very broad diversity in drug treatments was
noted for chronic tinnitus (Figure 2, right hand panels).
Reports by GPs regarding chronic tinnitus are shown in
the top right hand panel of Figure 2. For chronic tinni-
tus, anti-vertigo products were widely used by GPs
(average = 51.8%), but not as often as for acute tinnitus.
According to the data, patients visiting a GP in the UK
were most likely to be prescribed an anti-vertigo pro-
duct (acute tinnitus = 84% and chronic tinnitus = 88%).
The second most popular first-line treatment by GPs for
chronic tinnitus was an anti-depressant (average =
47.7%). As for acute tinnitus, pharmaceutical treatments
differed somewhat across countries. Tranquilisers were
common in Spain, the US, France and Italy (59%, 27%,
43% and 39%, respectively) and this pattern was broadly
repeated by ENTs for patients with chronic tinnitus too.
Corticosteroids were again used most often by GPs
practicing in the US (18%) and in Germany (26%), but
less commonly than for acute tinnitus. Also in Germany
was the continued GP preference for ginkgo prepara-
tions (58%), but while rheological infusion had been the
dominant treatment for acute tinnitus, it accounted for
only 35% of treatments offered to patients with chronic
tinnitus.
R e p o r t sb yE N T sr e g a r d i n gc h r o n i ct i n n i t u sa r e
shown in the bottom right hand panel of Figure 2.
ENTs appeared to be as likely to prescribe anti-vertigo
products for chronic tinnitus (average = 42.6%) as
they would for acute tinnitus. Again, patients visiting
ENT in the UK would most likely be prescribed an
anti-vertigo product (chronic tinnitus = 63% and
acute tinnitus = 50%) compared to any other type of
drug. The second most popular first line treatment by
ENTs for chronic tinnitus was Ginkgo biloba (average
= 52.3%), particularly in Germany (71%). Again, this
repeats a pattern observed for ENT treatment of acute
tinnitus. Anti-depressants and tranquilisers were also
prescribed for tinnitus in all six countries (average =
25.0% and 38.6%, respectively), but to a somewhat les-
ser degree in Germany. Overall, corticosteroids
accounted for fewer first-line drug treatment options
in cases of chronic tinnitus (average = 10.8%), than
acute tinnitus.
A number of country-specific preferences prevailed.
For example, in Spain, calcium antagonists accounted
for 65% of drug treatments, while ENTs in France used
coronary drugs most often (54%). In Italy, ENTs (like
their GP counterparts) preferred platelet aggregation
inhibitors (52%) as one of their first-line drug options.
Nootropic preparations were popular in Spain (58%),
France (43%) and Italy (45%), but were seldom used
elsewhere. Finally, rheological infusions in Germany
accounted for 52% of first line drug options.
For second-line medication options, the overall picture
was not well differentiated and so responses to the cor-
responding question (Q12) are not reported.
Satisfaction with medication options for subjective
tinnitus
The physicians were asked to rate their satisfaction with
current medications for treating subjective tinnitus on a
4-point scale and give reasons for selecting that answer
(Q13 and Q14, Appendix 1). GPs and ENTs responded
similarly with most of them (>60%) being dissatisfied
with current drug treatments (Table 10). There were no
striking differences of opinion across the six countries,
with the most common reason being a general lack of
effectiveness. In Germany, a large number of GPs and
ENTs also reported a high relapse rate (44% and 36%,
respectively).
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The physicians were asked to estimate what proportion
of treatments was successful for patients with subjective
tinnitus (Q15, Appendix 1). For chronic tinnitus, GPs
and ENTs rated treatments as being successful in
approximately one third of all cases (22-37% and 20-
57%, respectively). Success rate was judged to be some-
what better for acute tinnitus (GPs: 37-51% and ENTs:
43-61%). While this pattern was shared among most
countries, in the UK ENTs were markedly more positive
and perceived success in about 10% more cases of
chronic and acute tinnitus than the average.
Perceived challenges in treating subjective tinnitus
The questionnaire included a request to highlight any
problems in treating subjective tinnitus using current
standards of practice (Q16, Appendix 1). Respondents
from all six countries touched on the theme of effective-
ness (GPs: 37-60%; ENTs: 36-55%), highlighting a low
success rate as being a key problem. A range of other
issues were also raised, but these differed somewhat
from country to country and across the two professions.
For example, in France, a quarter of GPs were con-
cerned about the role of the patient’s psychological dis-
tress (24%), while one third of ENTs were concerned
about a lack of focus on treatment for depression (32%).
In Italy, many ENTs expressed patient’sr e s i s t a n c et o
therapy as problematic (27%), while in the US, the
shared concern for ENTs was the lack of possibilities to
treat the cause of tinnitus (23%).
Discussion
The present survey paints a picture in which the charac-
teristics of tinnitus (i.e. pathogenesis, duration and
severity) in those people seeking professional help are
perceived to be broadly the same across the six coun-
t r i e s .T h ed a t ai n d i c a t et h a tt h e‘most typical’ sort of
tinnitus patient seeking a consultation with their GP
tends to be someone with chronic subjective tinnitus
who has a repeat appointment. ENTs see many more
patients with tinnitus and these tend to be first-time
appointments, but again with chronic subjective tinnitus
as the defining feature. Despite these commonalities,
clinical provision differs greatly across countries; not
only in terms of their journey through the healthcare
system, but also in terms of the most likely options
offered to them for treating their tinnitus. In this Dis-
cussion, we summarize some of these issues emerging
from the present self-report data and speculate on the
key drivers behind those differences.
Principal differences in the roles of GPs and ENTs
Regarding treatment of chronic tinnitus, we observed
highly varying approaches, across professions and also
across countries. GPs are often the ‘first port of call’ for
a patient seeking help with their tinnitus, while most
ENTs see referred patients, typically from GPs, but also
from audiologists (UK) and neurologists (Germany).
Typically, GPs and ENTs reported that they were
responsible for diagnosing tinnitus in about two-thirds
of all cases. According to reports, there was a differing
level of involvement in tinnitus management. GPs in all
countries stated that around two thirds of patients were
managed by themselves, whereas a higher proportion of
tinnitus patients were reportedly treated by ENTs them-
selves. The survey highlighted the role of other profes-
sions in several European countries in terms of a role in
management. Notably this included specialists in neurol-
ogy in Germany, Italy and Spain and audiologists in the
UK and US. The involvement of neurologists may reflect
increasing awareness of the role of the central nervous
system for tinnitus generation and maintenance by GPs
and ENT specialists. In the following section, we
describe differences in the provision of hearing health-
care specialties which go some way to address the differ-
ing roles of the audiology profession.
Specialized clinical training in hearing problems
The healthcare system would appear to strongly deter-
mine how specialist treatment for tinnitus is provided.
In this section, we consider the training routes and pro-
fessional recognition of ENT and audiology specialties
Table 10 Percentages of satisfaction ratings by physicians regarding current medications for subjective tinnitus.
Very satisfied
[%]
Relatively satisfied
[%]
Not very satisfied
[%]
Completely dissatisfied
[%]
Country GP ENT GP ENT GP ENT GP ENT
US 5 3 34 14 57 60 4 24
UK 2 2 12 23 61 40 25 36
Germany 0 2 28 26 50 60 22 12
France 0 0 18 12 64 70 18 18
Spain 0 4 38 23 56 58 6 15
Italy 2 2 34 29 58 60 6 10
Ratings reported by each profession each sum to 100%.
Data are reported only for those physicians who saw at least one tinnitus patient in the past three months.
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Page 12 of 15across Europe and the US in order to contextualize
some of our findings, Otorhinolaryngology represents an
established area of health care for disorders of the head
and neck, including hearing, balance, sinus, nose, voice,
oral cavity, sleep, allergy, and head and neck tumors.
Within Europe, the European Union of Medical Specia-
lists (UEMS), founded in 1958, has ensured the quality
and harmonization of specialist training in order to sup-
port the free movement of qualified physicians and
patients. In otorhinolaryngology, this has been achieved
through a Charter in 1995 and a European training pro-
gramme in 2009 for head and neck surgery and ENT
specialists http://www.orluems.com/index.asp. In the
USA, the Accreditation Council for Graduate Medical
Education achieves similar aims, with 105 programs in
otolaryngology (2011-12) achieving national standards in
medical training http://www.acgme.org/adspublic/
reports/accredited_programs.asp.
In contrast, audiology represents a younger area of
health care for hearing and balance disorders, with spe-
cialist skills in rehabilitation especially in the provision
of hearing aids. In the US, audiology is recognized as an
i n d e p e n d e n tp r o f e s s i o ni ni t so w nr i g h t ,a n dt r a i n i n g
and practice are well regulated. In Europe however, the
situation is considerably more variable. Although the
profession is represented by the European Federation of
Audiology Societies (EFAS), founded in 1992, there is
no Europe-wide standard for training or professional
recognition. Specialist training in the UK and Scandana-
via has been well established for many years and EFAS
supports a proposal for a ‘General Audiologist profes-
sion’ to standardize the training curriculum and profes-
sional skills more widely. Training provision is growing
in some countries (e.g. Spain now offers two Masters in
Audiology courses on this model). However, it remains
unclear whether the structure and status of the audiol-
ogy profession can ever be consistent throughout Eur-
ope, given relative strength of the medical professions in
certain countries. For example, in Spain, audiology is
not an official profession, although hearing-aid techni-
cians were officially recognized in 2001.
It is interesting to note that in Europe other profes-
sions lay ‘claim’ to audiology and the EU perspective
from UEMS is one of audiology as a sub-speciality of
ENT. In Italy, audiology was previously a speciality
within ENT, but is now divided between ENT and pho-
niatrics (i.e., speech and language assessment and treat-
ment) (Ferdinando Grandori, personal communication).
In Germany, ENTs deal with differential diagnostics and
management of hearing loss, a second, independent
ENT specialty combines phoniatrics and pediatric
audiology [26] and hearing aid fitting is provided by the
independent speciality of hearing-aid technicians. Of the
five European countries surveyed here, the UK is
unusual in that audiology is a recognized specialism in
its own right and as a consequence is the primary health
system provider of treatmentsf o rc h r o n i ct i n n i t u s[ 2 5 ] .
In this respect, the UK system is more similar to that of
the US, than its European neighbours.
Training routes and recognized specialisms are there-
fore highly likely to contribute to the variability in clini-
cal practice across the different countries.
Management of acute subjective tinnitus: Key differences
across Europe and the US
A substantial proportion of responding GPs and ENTs
employed pharmaceutical treatment as a course of treat-
ment for acute subjective tinnitus, but countries appear to
differ in their use of drugs as a typical course of treatment
for acute tinnitus. Broadly speaking, the same patterns of
treatment for acute tinnitus were reported by GPs and
ENTs. Italy and Spain appear to use medications most fre-
quently, with the UK and US reporting the least usage.
T h es u r v e yf i n d i n g si n d i c a t et reatment with anti-vertigo
products or corticosteroids are widely accepted options.
Treatments involving some form of psychological
approach (including TRT) were most common in France,
Germany, UK and the US, while the UK and US also
offered acoustic devices. Physical therapy was most preva-
lent in France, Germany, the US and Italy. GPs in Ger-
many were noted as the only primary-care practitioners to
substantially offer rheological infusion and hyperbaric oxy-
genation treatments. In the absence of any robust evidence
base for the efficacy of drug treatments for subjective tin-
nitus, one might draw on anecdotal observations to begin
to understand these differences. For example, it is interest-
ing to note that in Germany, specialist hyperbaric oxygen
therapy centres have widely advertised the benefits of this
therapy for tinnitus perhaps thus increasing awareness in
the clinical profession and rheological infusion was cov-
ered by medical insurance at the time of the online survey.
These social and political contextual factors might exert
strong influences on healthcare decisions. Taking the US
as a comparison example where hyperbaric oxygen ther-
apy was rarely used, although some US alternative physi-
cians have extended the use of this treatment to include
tinnitus, to our knowledge tinnitus is not an indication
that is approved by the UHMS Hyperbaric Oxygen Ther-
apy Committee nor is it reimbursed by US medical insur-
ance (e.g. Medicare).
By way of minor comment we reflect on the possibility
that not all respondents approached this question from
the point of view of what they themselves would offer,
but instead responded according to what the local
healthcare system would typically offer. Evidence to sup-
port this view comes from the pattern of UK responses,
since acoustic devices are always provided by audiology
services, not by GPs and ENTs.
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Page 13 of 15Management of chronic subjective tinnitus: Key
differences across Europe and the US
A large number of patients develop chronic tinnitus and
so the greater challenge remains the management of
this long-lasting condition. Pharmacological interven-
tions appear to be less well regarded as effective for
chronic forms of tinnitus than for acute forms of the
condition, both by GPs and ENTs. Nevertheless, in Italy
and Spain medications were again prescribed more fre-
quently than elsewhere. Instead, a general trend was
observed for a greater usage of acoustic instruments and
psychological approaches. In addition to these conven-
tional therapies, clinicians were more likely to offer a
broad range of approaches the choice of which appeared
to be more driven by the country in which the clinician
was based than the form of subjective tinnitus being
presented. Again this suggests social and political factors
are more influential than clinical evidence regarding
efficacy.
Low satisfaction with available treatment options
This was unequivocally mentioned by both GPs and
ENTs from all investigated countries. Thus clinical
experiences under real-world conditions are in line with
systematic reviews and meta-analyses of controlled stu-
dies indicating low evidence for the efficacy of the var-
ious treatment options for tinnitus [14,16,27].
Conclusions
From the sample of physicians participating in this
survey, a wide variety of treatment approaches (both
pharmaceutical and non-pharmaceutical) appear to be
employed by GPs and ENTs across Europe and the
US, albeit all with rather poor patient outcomes.
While some commonalities in treatment approach
have been observed, substantial differences were noted
across the six countries, in part but not always related
to the national healthcare system. Healthcare profes-
sionals from all six countries express their dissatisfac-
tion with current practice and the results of this
survey highlight the need for an effective therapy
option, particularly for chronic subjective tinnitus,
with guidelines about how to use diagnostic criteria to
guide prescription
Appendix 1: Survey questions
Q1. How many patients with tinnitus problems in total
did you see in the last three months? And how many
new patients with tinnitus have come to you for treat-
ment within the last three months?
Q2. Tinnitus can be classified according to different
criteria, such as its pathogenesis (subjective vs. objec-
tive), its duration (acute vs. chronic) or the perceived
severity of the disorder (compensated vs. not
compensated). If you consider the cases that you saw in
the last three months, how could they be classified
according to these criteria?
Q3. Please consider your last 10 patients with subjec-
tive tinnitus. How many of these patients came to your
practice directly (without a referral) and how many were
referred to you by other doctors/specialists?
Q4. Which doctors/specialists made this referral?
Q5. Please think again about your last 10 patients with
subjective tinnitus in terms of their diagnosis. How
many of them did you diagnose yourself, how many
were already pre-diagnosed by another doctor and how
many did you refer to other specialists for further diag-
nostic confirmation?
Q6. You have just indicated that you referred of your
tinnitus patients to another specialist for diagnostics.
Who were these specialists?
Q7. Please think again about your last 10 patients with
subjective tinnitus in terms of their management. How
many of them did you manage yourself and how many
did you refer to other specialists for further
management?
Q8. You have just indicated that you referred of your
tinnitus patients to another specialist for further man-
agement. Who were these specialists?
Q9. Which course of treatment do you normally use
for patients with tinnitus? Please distinguish between
acute and chronic forms of tinnitus.
Select from list
Other (please give details)
Q10. Please consider your first-line treatment choices.
If you now think of your last 10 patients with acute sub-
jective tinnitus and your last 10 patients with chronic
subjective tinnitus: How would you categorise them in
the following courses of treatment?
Select from list
Other (please give details)
Patients not treated
Q11. If you treat subjective tinnitus with medication,
which would be your first-line treatment?
Select from list
Other (please give details)
No medication
Q12. Which medications do you use as second choice,
if your first line treatment is unsuccessful?
Select from list
Other (please give details)
No medication
Q13. How satisfied are you overall with current medi-
cations for treating subjective tinnitus?
Very satisfied
Relatively satisfied
Not very satisfied
Completely dissatisfied
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Page 14 of 15Q14. You have just indicated how satisfied you are
with current medications for treating subjective tinnitus.
Please give your reasons for choosing that answer in as
much detail as possible.
Q15. If you consider all of your patients with subjec-
tive tinnitus (both acute and chronic and regardless of
whether medication is used or not) for what proportion
of them do you believe that the treatment used has
been successful?
Q16. Are there any problems/difficulties with treating
subjective tinnitus that you are unable to solve by
means of the current standards of practice? If so, what
are these problems/difficulties in the management of
subjective tinnitus?
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